Discover Screener Plans Log In Sign Up
ALGN
Align Technology, Inc.
Summary
Business
Earnings Call
Valuation
Profitability
Financial Health
Intel
Yearly Return 10Y annualized return is very good at 11.4% per year
Earnings Expectations ALGN has met or exceeded earnings expectations in most recent quarters (9/10)
Positive Strong Gross Profit Margin
Positive Low Debt Levels
Negative High Price-to-Earnings Ratio
Negative High EV/EBITDA Ratio

Unlock Complete Analysis

Get access to all key takeaways, detailed financial metrics, and comprehensive stock analysis with our premium subscription.

Complete key takeaways analysis
Advanced financial metrics
Real-time insights & alerts
Start Your Premium Journey

Already have an account? Sign in

Overall, Align Technology demonstrates strong business quality through its diversified revenue streams, innovative product offerings, and robust practitioner engagement. However, pressures from foreign exchange rates and competition pose challenges. Future prospects remain positive, driven by growth in emerging markets and digital dentistry initiatives, but ASP declines and macroeconomic uncertainties present risks.

Analysis Date: February 5, 2025
Last Updated: May 29, 2025

+193%
+11.4% per year

Past performance does not guarantee future results. The data presented is indicative and may not be updated in real-time.

Country US
Exchange NASDAQ
Industry Medical - Devices
Sector Healthcare
Market Cap $16.50B
CEO Mr. Joseph M. Hogan

Align Technology, Inc. is a company that makes dental products to help people straighten their teeth. Their most famous product is Invisalign, which are clear aligners that can replace traditional metal braces. They also create iTero scanners, which dentists use to take digital images of patients' mouths. These tools help orthodontists and dentists provide better care and make it easier for patients to achieve a healthy smile.

Core Products

💻
CAD/CAM Services Design & manufacturing
📏
iTero Intraoral Scanner Digital scanning device
📚
Invisalign Training Fees Training for dentists
🦷
Invisalign Clear Aligners Custom clear braces
🖥️
Invisalign Outcome Simulator Treatment simulation tool

Business Type

B2B Business to Business

Competitive Advantages

Unlock Competitive Advantages Analysis

Discover all competitive advantages and strategic moats that protect ALGN's market position.

View Premium Analysis

Key Business Risks

Unlock Complete Risk Analysis

Get comprehensive insight into all key business risks that could impact ALGN's performance.

Access Full Risk Analysis

Trailing Twelve Months (TTM) values provide a view of the company's performance over the last year.

Graham Value Metrics

Benjamin Graham's value investing approach focuses on finding stocks with a significant margin of safety between their intrinsic value and market price.

📊

Unlock Graham value analysis

Access Benjamin Graham's value investing criteria, intrinsic value calculations, and margin of safety analysis

✓ Intrinsic value calculations
✓ Margin of safety analysis
✓ Complete Graham criteria checklist
✓ Value investing insights
Upgrade to Premium

ROE: 10.673727513260262

ROA: None

Gross Profit Margin: 69.59561077892296

Net Profit Margin: 10.288373593231382

Trailing Twelve Months (TTM) values provide a view of the company's performance over the last year.

Scroll horizontally to see more

About Profitability Metrics

Profitability metrics measure a company's ability to generate earnings relative to its revenue, operating costs, and other relevant metrics. Higher values generally indicate better performance.

📊

Unlock Profitability Metrics

Access detailed profitability metrics with visual gauges and benchmarks

  • • Return on Equity (ROE) analysis
  • • Return on Assets (ROA) insights
  • • Gross & Net Profit Margins
  • • Industry benchmark comparisons
Sign Up for Premium
💪

Unlock profitability strengths

Access detailed analysis of profitability strengths and positive performance indicators

Upgrade to Premium
⚠️

Unlock profitability weaknesses

Access detailed analysis of profitability weaknesses and areas of concern

Upgrade to Premium

About Financial Health Metrics

Financial health metrics assess a company's ability to meet its financial obligations and its overall financial stability.

🏦

Unlock Financial Health Metrics

Access detailed financial health metrics with visual gauges and risk assessments

  • • Debt to Equity ratio analysis
  • • Current ratio & liquidity insights
  • • Financial risk assessments
  • • Stability benchmarks
Sign Up for Premium
🛡️

Unlock financial strengths

Access detailed analysis of financial health strengths and stability indicators

Upgrade to Premium
⚠️

Unlock financial weaknesses

Access detailed analysis of financial health weaknesses and risk factors

Upgrade to Premium

Meeting Expectations

9 /10

Higher values indicate better execution and credibility

Recent Results

🔒

Unlock earnings history

View complete earnings history and detailed performance analysis

Upgrade to Premium

EPS

1.98
Estimated
2.13
Actual
+7.58%
Difference

Revenue

$975811650
Estimated
$979262000
Actual
+0.35%
Difference
💪

Unlock strenghts analysis

Unlock complete business strengths analysis

Upgrade to Premium
⚠️

Unlock weaknesses analysis

Unlock complete business weaknesses analysis

Upgrade to Premium
🚀

Unlock opportunities analysis

Unlock complete future opportunities analysis

Upgrade to Premium

Unlock risk analysis

Unlock complete future risks analysis

Upgrade to Premium

Insider trading data shows purchase and sale activities by company executives and board members.

Insider Sentiment Analysis

Insider trading patterns can provide insights into how company executives and board members view the stock's future prospects.

🔍

Unlock Insider Analysis

Get complete insider sentiment analysis with detailed trading patterns, sentiment indicators, and trend insights

  • • Insider buy/sell ratio analysis
  • • Total bought vs sold volumes
  • • Active insider tracking
  • • Recent trend analysis
Sign Up for Premium

ALGN Stock Analysis: Align Technology, Inc. Investment Guide

ALGN (Align Technology, Inc.) is a Healthcare company listed on NASDAQ Global Select. The stock has generated 11.4% annual returns with an overall investment score of None/100.

Overall, Align Technology demonstrates strong business quality through its diversified revenue streams, innovative product offerings, and robust practitioner engagement. However, pressures from foreign exchange rates and competition pose challenges. Future prospects remain positive, driven by growth in emerging markets and digital dentistry initiatives, but ASP declines and macroeconomic uncertainties present risks.

ALGN Key Financial Metrics

ALGN financial analysis includes comprehensive valuation ratios, profitability metrics, and financial health indicators. The company has a valuation score of 1.57234577809725/100 and profitability score of 3.75/100 with financial health rated 7.45/100.

About Align Technology, Inc.

Align Technology, Inc. is a company that makes dental products to help people straighten their teeth. Their most famous product is Invisalign, which are clear aligners that can replace traditional metal braces. They also create iTero scanners, which dentists use to take digital images of patients' mouths. These tools help orthodontists and dentists provide better care and make it easier for patients to achieve a healthy smile.

ALGN Investment Recommendation

Based on our comprehensive analysis of ALGN, investors should consider the company's strong performance track record, earnings consistency (9/10 quarters beat expectations), and current valuation metrics when making investment decisions.

Healthcare Sector Analysis

ALGN operates in the Medical - Devices industry within the Healthcare sector. This analysis compares Align Technology, Inc. performance against industry and sector benchmarks to provide context for investment decisions.

Frequently Asked Questions about ALGN Stock

Is ALGN a good investment?

ALGN (Align Technology, Inc.) has generated 11.4% annual returns with an overall score of None/100. Overall, Align Technology demonstrates strong business quality through its diversified revenue streams, innovative product offerings, and robust practitioner engagement. However, pressures from foreign exchange rates and competition pose challenges. Future … Investors should consider their risk tolerance and investment goals when evaluating ALGN.

What is ALGN P/E ratio and valuation?

ALGN valuation metrics including P/E ratio, price-to-book ratio, and price-to-sales ratio are analyzed on this page with comparisons to Medical - Devices industry and Healthcare sector benchmarks. The company currently has a valuation score of 1.57234577809725/100.

Should I buy ALGN stock now?

The decision to buy ALGN stock should be based on comprehensive analysis of financial metrics, market conditions, and individual investment goals. Our analysis provides profitability score of 3.75/100, financial health score of 7.45/100, and detailed performance metrics to help inform your investment decision.

What are ALGN financial health indicators?

ALGN financial health analysis includes liquidity ratios, debt levels, cash flow metrics, and profitability indicators. The company has a financial health score of 7.45/100 based on comprehensive analysis of balance sheet strength and operational efficiency.

How does ALGN compare to competitors?

ALGN performance is benchmarked against Medical - Devices industry peers and Healthcare sector averages. Our analysis includes comparative valuation ratios, profitability metrics, and growth indicators to provide context for Align Technology, Inc.'s market position.

What are ALGN historical returns?

ALGN has generated 11.4% annual returns over the 10Y. Historical performance analysis includes price appreciation, dividend yields, and total shareholder returns compared to market benchmarks.

ALGN Key Investment Metrics Summary

  • Annual Return: 11.4%
  • Valuation Score: 1.57234577809725/100
  • Profitability Score: 3.75/100
  • Financial Health Score: 7.45/100
  • Growth Score: -2.642236282066345/100
  • Earnings Beat Rate: 9/10 quarters
  • Sector: Healthcare
  • Industry: Medical - Devices
  • Exchange: NASDAQ Global Select
  • Market Cap: 16499828162

ALGN Investment Thesis

Align Technology, Inc. (ALGN) represents a strong investment opportunity in the Healthcare sector. With an overall score of None/100, the company demonstrates areas for financial improvement.

Investment Strengths

  • Strong Gross Profit Margin
  • Low Debt Levels
  • Strong Operating and Net Profit Margins
  • Healthy Return on Equity
  • Strong Liquidity Ratios
  • High Cash Per Share
  • Strong Revenue Growth Across Segments
  • Innovative Product Offerings
  • Strong Practitioner Engagement
  • Growth in Emerging Markets
  • Focus on Digital Dentistry
  • Projected Volume Growth

Investment Risks

  • High Price-to-Earnings Ratio
  • High EV/EBITDA Ratio
  • Interest Coverage Ratio Not Applicable
  • Pressure from Foreign Exchange Rates
  • Evolving Competitive Landscape
  • Anticipated ASP Declines
  • Macroeconomic Uncertainty
Home Screener Search Profile

During the beta period, we're currently displaying stocks from the S&P 500 index only. More stocks will be added soon.

Loading...